Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
87.5M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
10.8M
-
Shares change
-
+503K
-
Total reported value, excl. options
-
$101M
-
Value change
-
+$4.77M
-
Number of buys
-
32
-
Number of sells
-
-16
-
Price
-
$9.30
Significant Holders of Kura Oncology, Inc. - Common Stock (KURA) as of Q2 2017
53 filings reported holding KURA - Kura Oncology, Inc. - Common Stock as of Q2 2017.
Kura Oncology, Inc. - Common Stock (KURA) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.8M shares
of 87.5M outstanding shares and own 12.36% of the company stock.
Largest 10 shareholders include FMR LLC (2.82M shares), Partner Fund Management, L.P. (2.04M shares), EcoR1 Capital, LLC (2.03M shares), BlackRock Inc. (595K shares), MORGAN STANLEY (572K shares), Boxer Capital, LLC (533K shares), VANGUARD GROUP INC (434K shares), CLOUGH CAPITAL PARTNERS L P (421K shares), Minerva Advisors LLC (290K shares), and STATE STREET CORP (150K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.